Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides
暂无分享,去创建一个
[1] R. Phillips,et al. Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation , 1997, The Journal of experimental medicine.
[2] P. Bjorkman,et al. MHC Restriction in Three Dimensions: A View of T Cell Receptor/Ligand Interactions , 1997, Cell.
[3] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Stuart,et al. Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 , 1996, The Journal of experimental medicine.
[5] P. Klenerman,et al. Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants , 1995, Science.
[6] P. Sharp,et al. Cross-species transmission and recombination of 'AIDS' viruses. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[7] M. Busch,et al. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group , 1995, Journal of virology.
[8] A. Sette,et al. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. M. Howard,et al. Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria. , 1994, AIDS research and human retroviruses.
[10] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[11] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[12] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[13] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[14] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[15] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[16] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[17] D. Burke,et al. Phylogenetic analysis of gag genes from 70 international HIV‐1 isolates provides evidence for multiple genotypes , 1993, AIDS.
[18] P. Allen,et al. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.
[19] T. Elliott,et al. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. , 1993, Journal of immunological methods.
[20] M. Bevan,et al. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb‐restricted ovalbumin peptide and an assessment of the predictive power of MHC‐binding motifs , 1992, European journal of immunology.
[21] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[22] Timothy E. Elliott,et al. A quantitative assay of peptide‐dependent class I assembly , 1991, European journal of immunology.
[23] Wei-Shau Hu,et al. Retroviral recombination and reverse transcription. , 1990, Science.
[24] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[25] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[26] R. L. Kahn,et al. Complement Fixation with Protein Substances , 1918, The Journal of Immunology.
[27] Zinkernagel Rm,et al. Immunology - Promethean Viruses , 1994 .
[28] J Sninsky,et al. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. , 1989, Journal of acquired immune deficiency syndromes.